Salvage treatment incorporating arsenic trioxide for pediatric relapsed acute lymphoblastic leukemia: a retrospective real-world analysis
Relapsed pediatric acute lymphoblastic leukemia (ALL) confers an unfavorable prognosis. We evaluated the outcomes of an arsenic trioxide (ATO)-incorporating chemotherapy protocol in pediatric first-relapsed ALL. Patients were risk-stratified according to the ALL-REZ BFM 2002 protocol. Group A received an ins...